Plain-English translation of NCT06504927 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →Researchers are looking for special markers in blood that could help detect lung cancer earlier, before symptoms appear. The study collects blood samples from two groups: people with lung conditions like COPD or small nodules, and people with nodules that look more suspicious for cancer. By analyzing these blood samples, scientists hope to find patterns that can tell the difference between people at high risk and those who actually have lung cancer.
Doctors need better ways to catch lung cancer in its earliest stages, when treatment is most effective. This study aims to discover blood-based markers that could eventually help identify lung cancer earlier than current imaging methods alone.
You likely qualify if…
You likely don't qualify if…
You would visit the research clinic twice: once at the start, and once at your next scheduled lung imaging appointment. At your first visit, you'll provide about 30 milliliters (2 tablespoons) of blood. At your second visit, you'll provide about 21 milliliters of blood. You'll continue having your regular lung imaging scans as your doctor recommends, and researchers will analyze your blood samples to look for cancer markers.
AI-generated summary from trial data · Aug 8, 2026 · Not medical advice
Malaysia
Sponsor
University of Malaya
Collaborators
MiRXES Pte Ltd
Enrollment target
~400 participants
Started
January 2024
Primary completion
December 2026
Age range
30 Years and older
Last updated on clinicaltrials.gov in July 2024.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Mau Ern Poh
University of Malaya
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.